AffiAB® Anti-HLA-C Purified [DT-9]

https://www.affiab.com/web/image/product.template/105497/image_1920?unique=06fe5f0
(0 review)

CAT# AFG-EXB-0666
Size: 0.1 mg

228.50 228.5 USD 228.50

228.50

For Price Contact info@affigen.com

This combination does not exist.

Terms and Conditions
30-day money-back guarantee
Shipping: 2-3 Business Days

Overview

HLA-C, a member of MHC class I glycoproteins, is one of polymorphysm typing targets, which are important for transplantation. The HLA system plays an important role in the occurrence and outcome of infectious diseases. The structural spike and the nucleocapsid proteins of the novel coronavirus SARS-CoV-2, which causes coronavirus disease 2019 (COVID-19), are reported to contain multiple Class I epitopes with predicted HLA restrictions. Individual HLA genetic variation may help explain different immune responses to a virus across a population. It has been described that HLA-C interacts with human herpesvirus 8 MIR1 protein.


Specificity:

The mouse monoclonal antibody DT-9 recognizes an extracellular epitope on HLA-C member of MHC class I molecules. It does not crossreact with HLA-A or HLA-B allotypes.

Antigen

HLA-C

Clone

DT-9

Species Reactivity

Non-human primates, Human

Negative Species

N/A

Isotype

Mouse IgG2b

Immunogen

Purified MHC class I molecules of tamarin origin

Application

IP, FC (QC tested)

Regulatory status

RUO

Concentration

1 mg/ml

Format

Purified

Storage / Stability

Store at 2-8°C. Do not freeze.

Storage Buffer

Phosphate buffered saline (PBS), pH 7.4, 15 mM sodium azide